NCT02938793 2025-09-23Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid TumorsPrisma Health-UpstatePhase 2 Terminated92 enrolled
NCT00004682 2015-03-25Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia GravisFDA Office of Orphan Products DevelopmentPhase NA Terminated100 enrolled